ProfileGDS4718 / 242925_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 15% 13% 7% 8% 13% 19% 14% 11% 13% 13% 20% 11% 22% 9% 15% 19% 7% 8% 12% 14% 8% 14% 14% 14% 13% 12% 18% 9% 12% 20% 23% 12% 13% 17% 9% 10% 15% 13% 18% 7% 13% 16% 8% 14% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9833115
GSM549102patient 115, normal, homogenized [OPG study]3.8973213
GSM549104patient 119, normal, homogenized [OPG study]3.62247
GSM549108patient 138, normal, homogenized [OPG study]3.714368
GSM549119patient 077, normal, homogenized [OPG study]3.8778913
GSM549133patient 032, cancer, homogenized [OPG study]4.0570819
GSM549139patient 042, cancer, homogenized [OPG study]3.895514
GSM549099patient 107, normal, homogenized [OPG study]3.840911
GSM549109patient 139, normal, homogenized [OPG study]3.9320713
GSM549110patient 046, normal, homogenized [OPG study]3.8919613
GSM549114patient 063, normal, homogenized [OPG study]4.1007320
GSM549122patient 082, normal, homogenized [OPG study]3.8306911
GSM549134patient 033, cancer, homogenized [OPG study]4.2320522
GSM549136patient 036, cancer, homogenized [OPG study]3.704179
GSM549140patient 044, cancer, homogenized [OPG study]3.9477615
GSM549111patient 047, normal, homogenized [OPG study]4.0760619
GSM549113patient 057, normal, homogenized [OPG study]3.654587
GSM549132patient 031, cancer, homogenized [OPG study]3.703488
GSM549137patient 038, cancer, homogenized [OPG study]3.8441312
GSM549142patient 047, cancer, homogenized [OPG study]3.9986814
GSM549100patient 110, normal, homogenized [OPG study]3.694628
GSM549107patient 135, normal, homogenized [OPG study]3.9067714
GSM549115patient 068, normal, homogenized [OPG study]3.8915714
GSM549116patient 072, normal, homogenized [OPG study]3.9135414
GSM549120patient 078, normal, homogenized [OPG study]3.872113
GSM549131patient 030, cancer, homogenized [OPG study]3.8099312
GSM549118patient 074, normal, homogenized [OPG study]4.0626618
GSM549129patient 027, cancer, homogenized [OPG study]3.752489
GSM549123patient 088, normal, homogenized [OPG study]3.8544112
GSM549124patient 006, cancer, homogenized [OPG study]4.1939820
GSM549126patient 015, cancer, homogenized [OPG study]4.2434123
GSM549128patient 025, cancer, homogenized [OPG study]3.8220212
GSM549103patient 117, normal, homogenized [OPG study]3.9119313
GSM549117patient 073, normal, homogenized [OPG study]4.0178517
GSM549138patient 041, cancer, homogenized [OPG study]3.735149
GSM549141patient 045, cancer, homogenized [OPG study]3.7159310
GSM549130patient 028, cancer, homogenized [OPG study]3.9714615
GSM549101patient 111, normal, homogenized [OPG study]3.8990813
GSM549105patient 128, normal, homogenized [OPG study]4.0690118
GSM549106patient 134, normal, homogenized [OPG study]3.640717
GSM549112patient 048, normal, homogenized [OPG study]3.8858413
GSM549125patient 011, cancer, homogenized [OPG study]3.9970516
GSM549127patient 024, cancer, homogenized [OPG study]3.698988
GSM549135patient 035, cancer, homogenized [OPG study]3.8796814